Rossari Biotech

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE02A801020
  • NSEID: ROSSARI
  • BSEID: 543213
INR
609.30
8.3 (1.38%)
BSENSE

Dec 05

BSE+NSE Vol: 15.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Rossari Biotech Ltd stock-summary
stock-summary
Rossari Biotech Ltd
Small Cap
Specialty Chemicals
Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry. It was further renamed to Rossari Biotech Limited and converted into a company in 2009.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 11.06 Cr
Number of Shares
5.53 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
24-Jul-2024
5.53
11.06
3000
2
Issued under ESOP Scheme
20-Jul-2024
5.53
11.06
38800
2
Issued under ESOP Scheme
29-Apr-2024
5.52
11.05
1500
2
Issued under ESOP Scheme
20-Jan-2024
5.52
11.05
9350
2
Issued under ESOP Scheme
20-Oct-2023
5.52
11.05
9330
2
Issued under ESOP Scheme
28-Jul-2023
5.52
11.05
71800
2
Issued under ESOP Scheme
19-Jan-2023
5.52
11.03
3600
2
Issued under ESOP Scheme
07-Nov-2022
5.52
11.03
19250
0
Issued under ESOP Scheme
07-Nov-2022
5.52
11.03
19250
2
Issued under ESOP Scheme
06-Aug-2022
5.51
11.03
76250
2
Issued under ESOP Scheme
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 4 Schemes (13.27%)

FIIs

Held by 46 FIIs (2.69%)

Promoter with highest holding

Edward Menezes (29.11%)

Highest Public shareholder

Uti-flexi Cap Fund (6.29%)

Individual Investors Holdings

9.47%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Sunil Chari
Managing Director
1.11 cr
Edward Menezes
Chairman & Exec. Director
1.11 cr
Goutam Bhattacharya
Non-Exec. & Independent Dir.
25.8 lacs
Aseem Dhru
Non-Exec. & Independent Dir.
21.3 lacs
Sharabh Pachory
Non-Exec. & Independent Dir.
17.3 lacs
PARUL GUPTA
Company Sec. & Compli. Officer
0
Aparna Narendra Sharma
Addtnl Independent Director
0
Esha Padmanabhan Achan
Additional Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Acetic &CitricAcid
811.117
0%
 
100
Acetic &CitricAcid
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
586 Cr
(Quarterly Results - Sep 2025)
Net Profit:
37 Cr
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 3,326 Cr (Small Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.22

stock-summary
Return on Equity

10.92%

stock-summary
Price to Book

2.67